Jim Cramer Highlights Market Opportunities in Morning Meeting Points to Stock With Significant Upside Potential SpaceX IPO Speculation Drives Surge in SpaceTheme Stocks and ETFs M R Maniveni Foods IPO Day 1 Subscription Reaches 65 Led by NIIs Key Details Inside Michael Jacksons Catalog Hits New Highs on Global Charts Signaling Enduring Value Global Shares Rise Oil Prices Drop as Trump Indicates Progress in War Talks Microsoft and Anthropic in Talks for Custom AI Chip Deal After 5 Billion Investment SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues uniQure NV QURE Q1 2026 Earnings Narrower Loss Beats Estimates Shares Edge Lower BATL Q2 2023 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction KINS Q1 2026 Earnings EPS Misses Estimates Amid Challenging Underwriting Environment HireQuest Inc HQI Q1 2026 Earnings EPS Misses Estimate by Narrow Margin Shares Decline FGBIP Q1 2026 Earnings Strong EPS Beat Amid Quiet Market Reaction AppFolio Edges Higher as Shares Test Key Technical Levels comScore SCOR Surges Over 21 Key Levels and What Lies Ahead Oxford Lane Capital Preferred OXLCO Edges Higher Approaches Key Resistance Zone Hesai Group HSAI Slips 129 as Lidar Sector Faces Headwinds Support at 196 Under Watch Gaming and Leisure Properties GLPI Holds Steady Near Support as Real Estate Sector Shows Resilience Kraken Introduces Bitcoin Vault with Yield Generation for Investors Jefferson Capital Inc JCAP Q1 2026 Earnings EPS Beats Estimates but Stock Slides on Mixed Signals GBAB Edges Higher Navigating Yield and Resistance in a Taxable Municipal Bond CEF Koppers Holdings KOP Rallies 184 as Stock Approaches Key Resistance Level Pantages Capital Acquisition Rights PGACR Hold Steady at 021 Amid Narrow Trading Range Universal Display OLED Rises 279 as Shares Approach Key Resistance Level Redwood Trust Senior Notes RWTP Slide Marginally as Yield Attracts Cautious Traders BioRad Laboratories BIO Surges 44 as Bullish Momentum Builds From Key Support Level JELDWEN Holdings Surges Over 13 as Stock Approaches Key Resistance Level AEON Biopharma Dips 274 as Stock Nears Critical Support at 076